MOST NOTEWORTHY: U.S. Auto Parts, DealerTrack and AspenBio Pharma were today's noteworthy downgrades:
- Piper downgraded shares of U.S. Auto Parts (NASDAQ: PRTS) to Neutral from Buy following the company's Q4 results.
- JMP Securities cut DealerTrack (NASDAQ: TRAK) to Market Perform from Strong Buy as they believe future market share losses to RouteOne are more significant than previously believed.
- Oppenheimer has concerns that most of AspenBio Pharma's (NASDAQ: APPY) market value is tied to the AppyScore test for appendicitis, while available clinical data may not be sufficient to drive adoption. The firm lowered APPY to Perform from Outperform.
OTHER DOWNGRADES: